Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's disease
Raymond T. Bartus, Lamar Brown, Alistair Wilson, Brian Kruegel, Joao Siffert, Eugene M. Johnson Jr., Jeffrey H. Kordower, Christopher D. HerzogVolume:
44
Year:
2011
Language:
english
Pages:
15
DOI:
10.1016/j.nbd.2011.05.026
File:
PDF, 1.61 MB
english, 2011